| Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus CE Isaacs, GY Wen, W Xu, JH Jia, L Rohan, C Corbo, V Di Maggio, ... Antimicrobial agents and chemotherapy 52 (3), 962-970, 2008 | 221 | 2008 |
| Vaginal drug delivery systems for HIV prevention LC Rohan, AB Sassi The AAPS journal 11, 78-87, 2009 | 215 | 2009 |
| In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide LC Rohan, BJ Moncla, RP Kunjara Na Ayudhya, M Cost, Y Huang, F Gai, ... PLoS One 5 (2), e9310, 2010 | 195 | 2010 |
| Progress in antiretroviral drug delivery using nanotechnology R Mallipeddi, LC Rohan International journal of nanomedicine, 533-547, 2010 | 176 | 2010 |
| Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles AS Ham, MR Cost, AB Sassi, CS Dezzutti, LC Rohan Pharmaceutical research 26, 502-511, 2009 | 171 | 2009 |
| Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets S Garg, D Goldman, M Krumme, LC Rohan, S Smoot, DR Friend Antiviral research 88, S19-S29, 2010 | 156 | 2010 |
| Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis SS Olmsted, LA Meyn, LC Rohan, SL Hillier Sexually transmitted diseases 30 (3), 257-261, 2003 | 145 | 2003 |
| Griffithsin protects mice from genital herpes by preventing cell-to-cell spread B Nixon, M Stefanidou, PMM Mesquita, E Fakioglu, T Segarra, L Rohan, ... Journal of virology 87 (11), 6257-6269, 2013 | 139 | 2013 |
| Development and characterization of a vaginal film containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for prevention of HIV-1 sexual transmission A Akil, MA Parniak, CS Dezzutti, BJ Moncla, MR Cost, M Li, LC Rohan Drug delivery and translational research 1, 209-222, 2011 | 137 | 2011 |
| Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity CS Dezzutti, ER Brown, B Moncla, J Russo, M Cost, L Wang, K Uranker, ... PloS one 7 (11), e48328, 2012 | 135 | 2012 |
| Kunjara Na Ayudhya RP LC Rohan, BJ Moncla Cost M, Huang Y, Gai F, Billitto N, Lynam JD, Pryke K, Graebing P, Hopkins N …, 2010 | 125 | 2010 |
| Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment AN Fader, RP Edwards, M Cost, A Kanbour-Shakir, JL Kelley, B Schwartz, ... Gynecologic oncology 111 (1), 13-17, 2008 | 125 | 2008 |
| Degradation of naturally occurring and engineered antimicrobial peptides by proteases BJ Moncla, K Pryke, LC Rohan, PW Graebing Advances in bioscience and biotechnology (Print) 2 (6), 404, 2011 | 105 | 2011 |
| 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanisms E Michailidis, AD Huber, EM Ryan, YT Ong, MD Leslie, KB Matzek, ... Journal of Biological Chemistry 289 (35), 24533-24548, 2014 | 104 | 2014 |
| Nanoparticle-based vaginal drug delivery systems for HIV prevention R Mallipeddi, LC Rohan Expert opinion on drug delivery 7 (1), 37-48, 2010 | 103 | 2010 |
| Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis H Yang, J Li, SK Patel, KE Palmer, B Devlin, LC Rohan Pharmaceutics 11 (4), 184, 2019 | 92 | 2019 |
| Digallate dimers of (−)-epigallocatechin gallate inactivate herpes simplex virus CE Isaacs, W Xu, G Merz, S Hillier, L Rohan, GY Wen Antimicrobial agents and chemotherapy 55 (12), 5646-5653, 2011 | 91 | 2011 |
| Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) ZL Salie, KA Kirby, E Michailidis, B Marchand, K Singh, LC Rohan, ... Proceedings of the National Academy of Sciences 113 (33), 9274-9279, 2016 | 90 | 2016 |
| Vaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection AS Ham, LC Rohan, A Boczar, L Yang, K W. Buckheit, RW Buckheit Pharmaceutical research 29, 1897-1907, 2012 | 90 | 2012 |
| A phase 1 trial to assess the safety, acceptability, pharmacokinetics, and pharmacodynamics of a novel dapivirine vaginal film KE Bunge, CS Dezzutti, LC Rohan, CW Hendrix, MA Marzinke, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (5), 498-505, 2016 | 89 | 2016 |
